Publications by authors named "Mark Battle"

Claim this Profile
A
Alzheimer's Imaging Consortium.
Ariane Bollack, Christopher Buckley, Mark R Battle, Adam J Schwarz, Oskar Hansson

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Automated Tools for Lesion Detection on F Fluoroestradiol PET/CT Images and Assessment of Concordance with Standard-of-Care Imaging in Metastatic Breast Cancer.
Renee Miller, Mark Battle, Kristen Wangerin, Daniel T Huff, Amy J Weisman

Radiol Imaging Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study.
Lyduine E Collij, Gérard N Bischof, Daniele Altomare, Ilse Bader, Mark Battle

J Nucl Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centiloid recommendations for clinical context-of-use from the AMYPAD consortium.
Lyduine E Collij, Ariane Bollack, Renaud La Joie, Mahnaz Shekari, Santiago Bullich, Mark Battle

Alzheimers Dement· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
Merle Hönig, Daniele Altomare, Camilla Caprioglio, Lyduine Collij, Frederik Barkhof, Mark R Battle

Neurology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Software compatibility analysis for quantitative measures of [F]flutemetamol amyloid PET burden in mild cognitive impairment.
Hugh G Pemberton, Christopher Buckley, Mark Battle, Ariane Bollack, Vrajesh Patel

EJNMMI Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of amyloid PET for future clinical use: a state-of-the-art review.
Hugh G Pemberton, Lyduine E Collij, Fiona Heeman, Ariane Bollack, Mahnaz Shekari, Mark Battle

Eur J Nucl Med Mol Imaging· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load.
Antoine Leuzy, Johan Lilja, Christopher J Buckley, Rik Ossenkoppele, Sebastian Palmqvist, Mark Battle

Neurology· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centiloid scaling for quantification of brain amyloid with [F]flutemetamol using multiple processing methods.
Mark R Battle, Lovena Chedumbarum Pillay, Val J Lowe, David Knopman, Bradley Kemp

EJNMMI Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of Gross Photosynthesis, Respiration in the Light, and Mesophyll Conductance Using HO Labeling.
Paul P G Gauthier, Mark O Battle, Kevin L Griffin, Michael L Bender

Plant Physiol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-Met PET Imaging Detects Early-Stage Locoregional Recurrence of Basal-Like Breast Cancer.
Appitha Arulappu, Mark Battle, Michel Eisenblaetter, Graeme McRobbie, Imtiaz Khan

J Nucl Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor.
Alexander Jackson, Mark R Battle, Dennis M O'Shea, Wai-Fung Chau, Alessandra Gaeta

Nucl Med Biol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brain.
Melissa E Rodnick, Brian G Hockley, Phillip Sherman, Carole Quesada, Mark R Battle

Nucl Med Biol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of potential new fluorine-18 labelled radiotracers for imaging the GABA(A) receptor.
Alexander Jackson, Benedicte B Guilbert, Stuart D Plant, Julian Goggi, Mark R Battle

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent decreases in fossil-fuel emissions of ethane and methane derived from firn air.
Murat Aydin, Kristal R Verhulst, Eric S Saltzman, Mark O Battle, Stephen A Montzka

Nature· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent.
Mark R Battle, Julian L Goggi, Lucy Allen, Jon Barnett, Matthew S Morrison

J Nucl Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of 2-[(18)F]fluoroethylazide for the Staudinger ligation - Preparation and characterisation of GABA(A) receptor binding 4-quinolones.
Alessandra Gaeta, John Woodcraft, Stuart Plant, Julian Goggi, Paul Jones, Mark Battle

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polar firn air reveals large-scale impact of anthropogenic mercury emissions during the 1970s.
Xavier Faïn, Christophe P Ferrari, Aurélien Dommergue, Mary R Albert, Mark Battle

Proc Natl Acad Sci U S A· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
99mTc-NC100692--a tracer for imaging vitronectin receptors associated with angiogenesis: a preclinical investigation.
David Edwards, Paul Jones, Helena Haramis, Mark Battle, Rochelle Lear

Nucl Med Biol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biodistribution of NC100668 and the effect of excess NC100668 on the biodistribution and kidney retention of (99m)Tc-NC100668 in the rat.
David Edwards, Joanne Lewis, Mark Battle, Rochelle Lear, Gill Farrar

Nucl Med Biol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
99mTc-NC100668, an agent for imaging venous thromboembolism: The effect of anticoagulant or thrombolytic therapy on the uptake and retention of radioactivity in blood clots in vivo.
David Edwards, Joanne Lewis, Mark Battle, Rochelle Lear, Gill Farrar

Nucl Med Commun· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(99m)Tc-NC100668, a new tracer for imaging venous thromboemboli: pre-clinical biodistribution and incorporation into plasma clots in vivo and in vitro.
David Edwards, Joanne Lewis, Mark Battle, Rochelle Lear, Gill Farrar

Eur J Nucl Med Mol Imaging· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The in vivo and in vitro metabolic profile of 99mTc-NC100668, a new tracer for imaging venous thromboembolism: identification and biodistribution of the principal radiolabeled metabolite.
David Edwards, Mark Battle, Rochelle Lear, Gill Farrar, D Jon Barnett

Drug Metab Dispos· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The investigation of occult malignancies in patients with venous thromboembolism.
Mark Battle, Kate Evans, Jim Copper

Age Ageing· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probiotics and antibiotic associated diarrhoea. Lactulose is effective.
Mark Battle, Lara Teare, Sue Law, Jamie Fulton

BMJ· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis